Full-Time

Associate Medical Director/Medical Director

Confirmed live in the last 24 hours

Arrowhead Pharmaceuticals

Arrowhead Pharmaceuticals

51-200 employees

Develops RNAi-based therapies for genetic diseases

Biotechnology
Healthcare

Compensation Overview

$250k - $340kAnnually

Senior

Pasadena, CA, USA + 1 more

More locations: San Diego, CA, USA

Willingness to relocate to either San Diego or Pasadena, CA.

Category
Physicians & Surgeons
Medical, Clinical & Veterinary
Requirements
  • M.D., or Ph.D./M.D. combined with research experience
  • A strong desire to contribute to the development of meaningful therapeutics
  • Ability to effectively evaluate outside expert advice
  • Ability to clearly elucidate complex scientific and medical concepts via written and oral communication
  • Ability to work independently and effectively in a fast-paced, team-based, cross-functional environment
  • Strong interpersonal skills and the ability to communicate effectively with people in diverse and different settings
  • Excellent scientific communication skills (both verbal and technical) and interpersonal skills
  • Possesses sense of urgency without overlooking key details; identifies challenges and problems and takes the initiative to identify solutions
  • Results focused
  • Willingness to relocate if necessary to either Pasadena or San Diego, CA
Responsibilities
  • Support the conceptualization and design, development, execution and communication of clinical studies across a variety of therapeutic areas
  • Act as a medical lead in a cross functional team that includes medical, scientific, clinical, safety, program management and regulatory staff
  • Effectively communicate protocols and other relevant information with clinical site investigators and staff
  • Interpret clinical trial data and communicate results clearly and accurately
  • Provide ongoing clinical monitoring for clinical trials including but not limited to assessment of eligibility criteria, toxicity management, and drug safety surveillance
  • Contribute to documents, including IRB submissions, protocols, study reports, publications and regulatory submissions – including anticipated upcoming NDA/MAA submission
  • Provide high level and complex scientific and clinical guidance to Clinical Trials Management, Biometrics, Global Drug Safety, Regulatory and Project Management staff to meet project deliverables and timelines
  • Identify key opinion leaders and participate in clinical advisory board meetings
  • Make scientific presentations at advisory boards, key scientific meetings and external committee meetings
  • Identify and evaluate medical need and clinical path for new applications of RNA interference for the treatment of disease
  • Monitor and understand new developments in RNA interference in industry and academia
  • Support in-licensing and out-licensing activities and partner relationships
Arrowhead Pharmaceuticals

Arrowhead Pharmaceuticals

View

Arrowhead Pharmaceuticals develops medicines aimed at treating severe diseases by targeting and silencing specific genes. The company uses RNA interference (RNAi), a natural process that reduces gene expression, to create therapies that can potentially stop or reverse the progression of diseases like cystic fibrosis and hepatitis B. Their approach involves a variety of RNA chemistries and effective delivery methods to ensure deep and lasting effects on target genes. Unlike many competitors, Arrowhead focuses specifically on RNAi-based therapies, which allows them to address medical needs that are not met by existing treatments. Their goal is to provide new options for patients suffering from genetic disorders, and they generate revenue through partnerships, licensing agreements, and future sales of their therapies after regulatory approval.

Company Stage

IPO

Total Funding

$4.7M

Headquarters

Pasadena, California

Founded

2004

Simplify Jobs

Simplify's Take

What believers are saying

  • Arrowhead's recent $450 million funding round provides substantial financial resources to advance its drug pipeline and expand research initiatives.
  • Positive Phase 2 data for plozasiran and the initiation of an Expanded Access Program highlight the company's commitment to addressing unmet medical needs.
  • The company's diversified pipeline, including treatments for cystic fibrosis, hepatitis B, and myotonic dystrophy, offers multiple avenues for success.

What critics are saying

  • The high costs and lengthy timelines associated with drug development could strain Arrowhead's financial resources despite recent funding.
  • Regulatory hurdles and the potential for clinical trial failures pose significant risks to the company's drug approval process.

What makes Arrowhead Pharmaceuticals unique

  • Arrowhead Pharmaceuticals leverages RNA interference (RNAi) technology to target and silence disease-causing genes, setting it apart from traditional pharmaceutical approaches.
  • The company's proprietary TRiM platform enables tissue-specific targeting, enhancing the efficacy and safety of its therapies.
  • Strategic partnerships with major pharmaceutical companies like Takeda bolster Arrowhead's credibility and expand its research capabilities.

Help us improve and share your feedback! Did you find this helpful?